Cabaletta Bio, Inc.
CABA
$3.04
$0.124.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.20% | -5.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.95% | -8.54% | |||
| Operating Income | -3.95% | 8.54% | |||
| Income Before Tax | -3.81% | 6.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.81% | 6.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.81% | 6.57% | |||
| EBIT | -3.95% | 8.54% | |||
| EBITDA | -4.01% | 8.61% | |||
| EPS Basic | 2.90% | 8.82% | |||
| Normalized Basic EPS | 2.88% | 8.83% | |||
| EPS Diluted | 2.90% | 8.82% | |||
| Normalized Diluted EPS | 2.88% | 8.83% | |||
| Average Basic Shares Outstanding | 6.90% | 2.48% | |||
| Average Diluted Shares Outstanding | 6.90% | 2.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||